| 标题 |
Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor: analysis of the FDA Adverse Event Reporting System (FAERS) database |
| 网址 | |
| DOI | |
| 其它 |
期刊:Expert Opinion on Drug Safety 作者:Michael B. Andrews; Douglas G. Adler 出版日期:2025-06-12 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)